Showing results (351-360 of 522) with videos related to

Sort By:
Pageof 53
Blood Cancer Journal|August 10, 2020
Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burdenDaniel J DeAngelo, Anjali S Advani, David I Marks, et al.
Bone Marrow Transplantation|March 2, 2011
The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation studyR E Protheroe, K E Kirkland, R M Pearce, et al.
The British Journal of Dermatology|June 14, 2005
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trialA B Gottlieb, C E M Griffiths, V C Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 1, 2019
Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic LeukemiaDavid I Marks, Partow Kebriaei, Matthias Stelljes, et al.
British Journal of Haematology|September 27, 2003
The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantationJ Paul Kerr, Effie Liakopolou, Jessica Brown, et al.
Transfusion Medicine (Oxford, England)|May 18, 2012
The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasmaEdwin Massey, Kay Harding, Brennan C Kahan, et al.
British Journal of Haematology|August 29, 1998
The outcome of children requiring admission to an intensive care unit following bone marrow transplantationC Hayes, R J Lush, J M Cornish, et al.
Blood|April 27, 2011
Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemiaJudith C Marsh, Vikas Gupta, Ziyi Lim, et al.
Annals of Internal Medicine|August 1, 1993
Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 yearsD I Marks, J O Cullis, K N Ward, et al.
Bone Marrow Transplantation|November 26, 2008
Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AMLR K Malladi, A J Peniket, T J Littlewood, et al.
Pageof 53